Gastroesophageal Reflux DiseasePARADENCT00829738
Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease
An observational study of Gastroesophageal Reflux Disease, run by Nycomed at 717 sites in Germany.
Trial summary
The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population. Read more about this study
- Who is it for?
- Ages 12 years and older
- Conditions the study is for
- Gastroesophageal Reflux Disease
- What is being tested?
- Pantoprazole
- How many people
- 4,188 participants
- Where
- 717 sitesGermany
- Study dates
- Jan 2009to Jun 2009
- Phase
- Observational
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Outpatients
Main inclusion criteria:
- Outpatients with gastroesophageal reflux disease (GERD)
Main exclusion criteria:
- Criteria as defined in the Summary of Product Characteristics
Trial locations and contacts
717 sites in 1 country.
300 sites in 1 country
Germany300 sites
Nycomed Deutschland GmbH
Aachen, 52072
Nycomed Deutschland GmbH
Aachen, 52078
Nycomed Deutschland GmbH
Ahrensburg, 22926
Nycomed Deutschland GmbH
Alpenrod, 57642
Nycomed Deutschland GmbH
Altenburg, 04600
Nycomed Deutschland GmbH
Altenholz, 24161
Nycomed Deutschland GmbH
Altenkirchen, 66903
Nycomed Deutschland GmbH
Altflußheim, 68804
Nycomed Deutschland GmbH
Alzenau in Unterfranken, 63755
Nycomed Deutschland GmbH
Angermünde, 16278
Nycomed Deutschland GmbH
Anklam, 17389
Nycomed Deutschland GmbH
Annweiler am Trifels, 76855
Nycomed Deutschland GmbH
Ansbach, 91522
Nycomed Deutschland GmbH
Apolda, 99510
Nycomed Deutschland GmbH
Arnstadt, 99310
Nycomed Deutschland GmbH
Ascheberg, 24326
Nycomed Deutschland GmbH
Aschendorf, 26871
Nycomed Deutschland GmbH
Aschersleben, 06449
Nycomed Deutschland GmbH
Aue, 08280
Nycomed Deutschland GmbH
Augsburg, 86159
Nycomed Deutschland GmbH
Augsburg, 86163
Nycomed Deutschland GmbH
Augustusburg, 09573
Nycomed Deutschland GmbH
Aumühle, 21521
Nycomed Deutschland GmbH
Babenhausen, 64832
Nycomed Deutschland GmbH
Bad Arolsen, 34454
Nycomed Deutschland GmbH
Bad Berka, 99438
Nycomed Deutschland GmbH
Bad Berleburg, 57319
Nycomed Deutschland GmbH
Bad Bevensen, 29549
Nycomed Deutschland GmbH
Bad Bramstedt, 24576
Nycomed Deutschland GmbH
Bad Doberan, 18209
Nycomed Deutschland GmbH
Bad Dürkheim, 67098
Nycomed Deutschland GmbH
Bad Langensalza, 99947
Nycomed Deutschland GmbH
Bad Liebenwerda, 04924
Nycomed Deutschland GmbH
Bad Oeynhausen, 32547
Nycomed Deutschland GmbH
Bad Oldesloe, 23843
Nycomed Deutschland GmbH
Bad Orb, 63619
Nycomed Deutschland GmbH
Bad Pyrmont, 31812
Nycomed Deutschland GmbH
Bad Rappenau, 74906
Nycomed Deutschland GmbH
Bad Salzuflen, 32108
Nycomed Deutschland GmbH
Bad Sassendorf, 59505
Nycomed Deutschland GmbH
Bad Schwalbach, 65307
Nycomed Deutschland GmbH
Bad Tölz, 83646
Nycomed Deutschland GmbH
Bad Windsheim, 91438
Nycomed Deutschland GmbH
Bad Winsheim, 91438
Nycomed Deutschland GmbH
Badel, 39624
Nycomed Deutschland GmbH
Bahrdorf, 38459
Nycomed Deutschland GmbH
Bakum, 49456
Nycomed Deutschland GmbH
Balingen, 72336
Nycomed Deutschland GmbH
Bamberg, 96052
Nycomed Deutschland GmbH
Barmstedt, 25355
Nycomed Deutschland GmbH
Bausendorf, 54538
Nycomed Deutschland GmbH
Bechhofen, 66894
Nycomed Deutschland GmbH
Beckum, 59269
Nycomed Deutschland GmbH
Beckum-Neubeckum, 59269
Nycomed Deutschland GmbH
Bergisch Gladbach, 51429
Nycomed Deutschland GmbH
Bergisch Gladbach, 51465
Nycomed Deutschland GmbH
Bergisch Gladbach, 51469
Nycomed Deutschland GmbH
Bergkamen, 59192
Nycomed Deutschland GmbH
Berlin, 10119
Nycomed Deutschland GmbH
Berlin, 10318
Nycomed Deutschland GmbH
Berlin, 10367
Nycomed Deutschland GmbH
Berlin, 10407
Nycomed Deutschland GmbH
Berlin, 10409
Nycomed Deutschland GmbH
Berlin, 10437
Nycomed Deutschland GmbH
Berlin, 10557
Nycomed Deutschland GmbH
Berlin, 10717
Nycomed Deutschland GmbH
Berlin, 10719
Nycomed Deutschland GmbH
Berlin, 10779
Nycomed Deutschland GmbH
Berlin, 10827
Nycomed Deutschland GmbH
Berlin, 10967
Nycomed Deutschland GmbH
Berlin, 10997
Nycomed Deutschland GmbH
Berlin, 12057
Nycomed Deutschland GmbH
Berlin, 12101
Nycomed Deutschland GmbH
Berlin, 12351
Nycomed Deutschland GmbH
Berlin, 12459
Nycomed Deutschland GmbH
Berlin, 12524
Nycomed Deutschland GmbH
Berlin, 12555
Nycomed Deutschland GmbH
Berlin, 12559
Nycomed Deutschland GmbH
Berlin, 12587
Nycomed Deutschland GmbH
Berlin, 12623
Nycomed Deutschland GmbH
Berlin, 12627
Nycomed Deutschland GmbH
Berlin, 12683
Nycomed Deutschland GmbH
Berlin, 12687
Nycomed Deutschland GmbH
Berlin, 13055
Nycomed Deutschland GmbH
Berlin, 13127
Nycomed Deutschland GmbH
Berlin, 13187
Nycomed Deutschland GmbH
Berlin, 13347
Nycomed Deutschland GmbH
Berlin, 13357
Nycomed Deutschland GmbH
Berlin, 13359
Nycomed Deutschland GmbH
Berlin, 13409
Nycomed Deutschland GmbH
Berlin, 13439
Nycomed Deutschland GmbH
Berlin, 13507
Nycomed Deutschland GmbH
Berlin, 13581
Nycomed Deutschland GmbH
Berlin, 13597
Nycomed Deutschland GmbH
Berlin, 14052
Nycomed Deutschland GmbH
Berlin, 14089
Nycomed Deutschland GmbH
Berlin, 14193
Nycomed Deutschland GmbH
Berlin, 14199
Nycomed Deutschland GmbH
Bernburg, 06406
Nycomed Deutschland GmbH
Berne, 27804
Nycomed Deutschland GmbH
Bernkastel-Kues, 54470
Nycomed Deutschland GmbH
Beucha, 04824
Nycomed Deutschland GmbH
Beverungen, 37688
Nycomed Deutschland GmbH
Bielefeld, 33602
Nycomed Deutschland GmbH
Bielefeld, 33739
Nycomed Deutschland GmbH
Bietigheim-Bissingen, 74321
Nycomed Deutschland GmbH
Birkendorf, 79777
Nycomed Deutschland GmbH
Birkenwerder, 16547
Nycomed Deutschland GmbH
Blankenhain, 99444
Nycomed Deutschland GmbH
Blieskastel, 66440
Nycomed Deutschland GmbH
Böblingen, 71032
Nycomed Deutschland GmbH
Bochum, 44791
Nycomed Deutschland GmbH
Bochum, 44805
Nycomed Deutschland GmbH
Böhlen, 04564
Nycomed Deutschland GmbH
Bonn, 53115
Nycomed Deutschland GmbH
Bonn, 53121
Nycomed Deutschland GmbH
Bonndorf, 79848
Nycomed Deutschland GmbH
Borna, 04552
Nycomed Deutschland GmbH
Brake, 26919
Nycomed Deutschland GmbH
Brakel, 33034
Nycomed Deutschland GmbH
Braunschweig, 38106
Nycomed Deutschland GmbH
Braunschweig, 38112
Nycomed Deutschland GmbH
Brausbedra, 08242
Nycomed Deutschland GmbH
Breidenbach, 35236
Nycomed Deutschland GmbH
Bremen, 28327
Nycomed Deutschland GmbH
Bremen, 28359
Nycomed Deutschland GmbH
Bremen, 28759
Nycomed Deutschland GmbH
Bremen-Lehe, 28359
Nycomed Deutschland GmbH
Bremerhaven, 27570
Nycomed Deutschland GmbH
Bremerhaven, 27580
Nycomed Deutschland GmbH
Brilon, 59929
Nycomed Deutschland GmbH
Bröckel, 29356
Nycomed Deutschland GmbH
Bruchsal, 76646
Nycomed Deutschland GmbH
Brühl, 50321
Nycomed Deutschland GmbH
Brühl-Pingsdorf, 50321
Nycomed Deutschland GmbH
Buckow, 15377
Nycomed Deutschland GmbH
Büdingen, 63654
Nycomed Deutschland GmbH
Burgdorf, Hanover, 31303
Nycomed Deutschland GmbH
Burgstädt, 09217
Nycomed Deutschland GmbH
Butzbach, 35510
Nycomed Deutschland GmbH
Castrop-Rauxel, 44575
Nycomed Deutschland GmbH
Castrop-Rauxel, 44577
Nycomed Deutschland GmbH
Chemnitz, 09113
Nycomed Deutschland GmbH
Chemnitz, 09126
Nycomed Deutschland GmbH
Chemnitz, 09130
Nycomed Deutschland GmbH
Chemnitz, 09224
Nycomed Deutschland GmbH
Chemnitz, 9123
Nycomed Deutschland GmbH
Cismar, 23743
Nycomed Deutschland GmbH
Claußnitz, 09236
Nycomed Deutschland GmbH
Clausthal-Zellerfeld, 38678
Nycomed Deutschland GmbH
Coesfeld, 48653
Nycomed Deutschland GmbH
Cologne, 50670
Nycomed Deutschland GmbH
Cologne, 50733
Nycomed Deutschland GmbH
Cologne, 50825
Nycomed Deutschland GmbH
Cologne, 50827
Nycomed Deutschland GmbH
Cologne, 51069
Nycomed Deutschland GmbH
Cologne, 51103
Nycomed Deutschland GmbH
Dabel, 19406
Nycomed Deutschland GmbH
Darmstadt, 64233
Nycomed Deutschland GmbH
Deggingen, 73326
Nycomed Deutschland GmbH
Delitzsch, 04509
Nycomed Deutschland GmbH
Dessau, 06844
Nycomed Deutschland GmbH
Dierdorf, 56269
Nycomed Deutschland GmbH
Dillingen, 66763
Nycomed Deutschland GmbH
Dillingen-Diefflen, 66763
Nycomed Deutschland GmbH
Dinslaken, 46535
Nycomed Deutschland GmbH
Dinslaken, 46539
Nycomed Deutschland GmbH
Dörpen, 26892
Nycomed Deutschland GmbH
Dorsten, 46282
Nycomed Deutschland GmbH
Dortmund, 44359
Nycomed Deutschland GmbH
Dortmund, 44369
Nycomed Deutschland GmbH
Dortmund, 44388
Nycomed Deutschland GmbH
Dörzbach, 74677
Nycomed Deutschland GmbH
Dreetz, 16845
Nycomed Deutschland GmbH
Dresden, 01069
Nycomed Deutschland GmbH
Dresden, 01127
Nycomed Deutschland GmbH
Dresden, 01129
Nycomed Deutschland GmbH
Dresden, 01139
Nycomed Deutschland GmbH
Dresden, 01159
Nycomed Deutschland GmbH
Dresden, 01239
Nycomed Deutschland GmbH
Dresden, 01259
Nycomed Deutschland GmbH
Dresden, 01307
Nycomed Deutschland GmbH
Dresden, 01309
Nycomed Deutschland GmbH
Duisburg, 47051
Nycomed Deutschland GmbH
Duisburg, 47178
Nycomed Deutschland GmbH
Duisburg, 47226
Nycomed Deutschland GmbH
Dummerstorf, 18196
Nycomed Deutschland GmbH
Düren, 52351
Nycomed Deutschland GmbH
Düren, 52355
Nycomed Deutschland GmbH
Dürrröhrsdorf, 01833
Nycomed Deutschland GmbH
Düsseldorf, 40212
Nycomed Deutschland GmbH
Düsseldorf, 40468
Nycomed Deutschland GmbH
Düsseldorf, 40489
Nycomed Deutschland GmbH
Düsseldorf, 40629
Nycomed Deutschland GmbH
Ebeleben, 99713
Nycomed Deutschland GmbH
Ebersbach, 02730
Nycomed Deutschland GmbH
Eggenstein, 76344
Nycomed Deutschland GmbH
Ehingen, 89584
Nycomed Deutschland GmbH
Eimsheim, 55278
Nycomed Deutschland GmbH
Einbeck, 37574
Nycomed Deutschland GmbH
Eisenfeld, 63820
Nycomed Deutschland GmbH
Eisenhüttenstadt, 15890
Nycomed Deutschland GmbH
Eisfeld, 98673
Nycomed Deutschland GmbH
Eiterfeld, 36132
Nycomed Deutschland GmbH
Ellerstadt, 67158
Nycomed Deutschland GmbH
Elmshorn, 25335
Nycomed Deutschland GmbH
Elsenfeld, 63820
Nycomed Deutschland GmbH
Emleben, 99869
Nycomed Deutschland GmbH
Emmendingen, 79312
Nycomed Deutschland GmbH
Emsdetten, 48282
Nycomed Deutschland GmbH
Engelskirchen-Ründeroth, 51766
Nycomed Deutschland GmbH
Eningen unter Achalm, 72800
Nycomed Deutschland GmbH
Enkenbach-Alsenborn, 67677
Nycomed Deutschland GmbH
Erfurt, 99084
Nycomed Deutschland GmbH
Erfurt, 99085
Nycomed Deutschland GmbH
Erfurt, 99086
Nycomed Deutschland GmbH
Erfurt, 99094
Nycomed Deutschland GmbH
Eschelbronn, 74927
Nycomed Deutschland GmbH
Eschwege, 37269
Nycomed Deutschland GmbH
Essen, 45136
Nycomed Deutschland GmbH
Essen, 45355
Nycomed Deutschland GmbH
Essen, 45356
Nycomed Deutschland GmbH
Essen, 49632
Nycomed Deutschland GmbH
Fehmarn, 23769
Nycomed Deutschland GmbH
Fehrbellin, 16833
Nycomed Deutschland GmbH
Feldafing, 82340
Nycomed Deutschland GmbH
Felsberg-Gensungen, 34587
Nycomed Deutschland GmbH
Finsterwalde, 03238
Nycomed Deutschland GmbH
Flensburg, 24939
Nycomed Deutschland GmbH
Flöha, 09557
Nycomed Deutschland GmbH
Flonheim, 55237
Nycomed Deutschland GmbH
Framersheim, 55234
Nycomed Deutschland GmbH
Frankenberg/Eder, 35066
Nycomed Deutschland GmbH
Frankenthal, 67227
Nycomed Deutschland GmbH
Frankfurt, 60389
Nycomed Deutschland GmbH
Freiburg im Breisgau, 21729
Nycomed Deutschland GmbH
Freiburg im Breisgau, 79104
Nycomed Deutschland GmbH
Freiburg im Breisgau, 79110
Nycomed Deutschland GmbH
Freinsheim, 67251
Nycomed Deutschland GmbH
Freising, 85354
Nycomed Deutschland GmbH
Freising, 85356
Nycomed Deutschland GmbH
Freyung, 94078
Nycomed Deutschland GmbH
Friedersdorf, 15754
Nycomed Deutschland GmbH
Friedrichshafen, 88045
Nycomed Deutschland GmbH
Friedrichshafen, 88046
Nycomed Deutschland GmbH
Friedrichsthal, 66299
Nycomed Deutschland GmbH
Friesenheim, 77948
Nycomed Deutschland GmbH
Frohburg, 04654
Nycomed Deutschland GmbH
Fürstenstein, 94538
Nycomed Deutschland GmbH
Fürstenwalde, 15517
Nycomed Deutschland GmbH
Fürth, 90762
Nycomed Deutschland GmbH
Fürth, 90763
Nycomed Deutschland GmbH
Gebesee, 99189
Nycomed Deutschland GmbH
Gefell, 07926
Nycomed Deutschland GmbH
Geisenheim, 65366
Nycomed Deutschland GmbH
Gelnhausen, 63571
Nycomed Deutschland GmbH
Gelsenkirchen, 45881
Nycomed Deutschland GmbH
Gelsenkirchen, 45883
Nycomed Deutschland GmbH
Gelsenkirchen, 45884
Nycomed Deutschland GmbH
Gelsenkirchen, 45886
Nycomed Deutschland GmbH
Gelsenkirchen, 45888
Nycomed Deutschland GmbH
Georgsmarienhütte, 49124
Nycomed Deutschland GmbH
Gera, 07545
Nycomed Deutschland GmbH
Gera, 07552
Nycomed Deutschland GmbH
Geretsried, 82538
Nycomed Deutschland GmbH
Germering, 82110
Nycomed Deutschland GmbH
Gernrode, 37339
Nycomed Deutschland GmbH
Gladbeck, 45966
Nycomed Deutschland GmbH
Gleichen, 37130
Nycomed Deutschland GmbH
Görlitz, 02827
Nycomed Deutschland GmbH
Goslar, 38640
Nycomed Deutschland GmbH
Goßwitz, 07334
Nycomed Deutschland GmbH
Göttingen, 37081
Nycomed Deutschland GmbH
Göttingen-Elliehausen, 37079
Nycomed Deutschland GmbH
Gräfinau-Angstedt, 98704
Nycomed Deutschland GmbH
Greifswald, 17489
Nycomed Deutschland GmbH
Greiz, 07973
Nycomed Deutschland GmbH
Grevenbroich, 41515
Nycomed Deutschland GmbH
Grevesmühlen, 23936
Nycomed Deutschland GmbH
Grimma, 04668
Nycomed Deutschland GmbH
Gröden, 04932
Nycomed Deutschland GmbH
Groitzsch, 04539
Nycomed Deutschland GmbH
Grömitz, 23743
Nycomed Deutschland GmbH
Großaitingen, 86845
Nycomed Deutschland GmbH
Großefehn, 26629
Nycomed Deutschland GmbH
Großenehrich, 99718
Nycomed Deutschland GmbH
Großkorbetha, 06688
Nycomed Deutschland GmbH
Gundelsheim, 96163
Nycomed Deutschland GmbH
Güstrow, 18273
Nycomed Deutschland GmbH
Gütersloh, 33330
Nycomed Deutschland GmbH
Hagenow, 19230
Nycomed Deutschland GmbH
Halbe, 15757
Nycomed Deutschland GmbH
Halberstadt, 38820
Nycomed Deutschland GmbH
Halle, 06110
Nycomed Deutschland GmbH
Halle, 06114
Nycomed Deutschland GmbH
Hamburg, 20099
Nycomed Deutschland GmbH
Hamburg, 20357
Nycomed Deutschland GmbH
Hamburg, 21079
Nycomed Deutschland GmbH
Hamburg, 22111
Nycomed Deutschland GmbH
Hamburg, 22177
About this study
Official title: Pantoprazole 20/40 mg in Reflux-Associated Complaints With Focus on Gastrointestinal Symptoms
The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population.
- Conditions
- Gastroesophageal Reflux Disease
- Being tested
- Pantoprazole
- Keywords
- PPI therapy, pantoprazole, GERD (Erosive Gastroesophageal Reflux Disease)
- Medical subject headings
- Gastroesophageal Reflux
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PantoprazoleDrug
This was an observational study. Therefore, the physician decided about dosage according to individual needs (20 or 40 mg pantoprazole).
| Study group | Role | What they receive |
|---|---|---|
| Group 1 | All patients enrolled Receives: Drug: Pantoprazole |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Heartburn
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: 14 days
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Eructation/Sour Eructation
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: 14 days
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Painful Swallowing
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: 14 days
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Reflux Symptoms
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Measured: 14 days
Secondary outcomes (9)
Functional Dyspepsia Symptoms: Assessment of the Severity of Upper Abdominal Pain
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: 14 days
Functional Dyspepsia Symptoms: Assessment of the Severity of Sensation of Fullness
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: 14 days
Functional Dyspepsia Symptoms: Assessment of the Severity of Nausea
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: 14 days
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Dyspeptic Symptoms
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Measured: 14 days
Irritable Bowel Syndrome: Assessment of the Severity of Lower Abdominal Pain
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: 14 days
Irritable Bowel Syndrome: Assessment of the Severity of Diarrhoea
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: 14 days
Irritable Bowel Syndrome: Assessment of the Severity of Constipation
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: 14 days
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Irritable Bowel Syndrome
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Measured: 14 days
Assessment of the Tolerability of Pantoprazole at Final Visit
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Measured: 14 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jan 2009 (estimated)
- Study startJan 2009
- Primary completionApr 2009
- Study completionJun 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Gastroesophageal Reflux DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 4,188 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nycomed
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Thomas D. Bethke, MD, MBA, Study director, Nycomed Deutschland GmbH, 78467 Konstanz, Germany
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00829738
- Sponsor's protocol ID
- P2-9999-011-DE
- Acronym
- PARADE
- Status last verified
- May 2012
- First submitted
- 13 Jan 2009
- Last updated
- 8 May 2012
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pantoprazole 20/40 mg in Reflux-Associated Complaints With Focus on Gastrointestinal Symptoms
- ClinicalTrials.gov ID
- NCT00829738
- Acronym / sponsor ID
- PARADE / P2-9999-011-DE
- Conditions
- Gastroesophageal Reflux Disease
- Keywords
- PPI therapy, pantoprazole, GERD (Erosive Gastroesophageal Reflux Disease)
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 4,188 participants (actual)
- Lead sponsor
- NycomedIndustry (pharma, biotech, devices)
- Study start
- Jan 2009
- Primary completion
- Apr 2009 (actual)
- Study completion
- Jun 2009 (actual)
- First posted
- 27 Jan 2009 (estimated)
- Results
- Posted 24 Sep 2010
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Group 1 | – | Drug: PantoprazoleAll patients enrolled |
Who may qualify
- Ages
- 12 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Outpatients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PantoprazoleThis was an observational study. Therefore, the physician decided about dosage according to individual needs (20 or 40 mg pantoprazole). | Drug | Group 1 |
Primary outcome
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Heartburn
Time frame: 14 days
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Eructation/Sour Eructation
Time frame: 14 days
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Painful Swallowing
Time frame: 14 days
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Reflux Symptoms
Time frame: 14 days
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
9 secondary outcomes
Functional Dyspepsia Symptoms: Assessment of the Severity of Upper Abdominal Pain
Time frame: 14 days
Functional Dyspepsia Symptoms: Assessment of the Severity of Sensation of Fullness
Time frame: 14 days
Functional Dyspepsia Symptoms: Assessment of the Severity of Nausea
Time frame: 14 days
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Dyspeptic Symptoms
Time frame: 14 days
Irritable Bowel Syndrome: Assessment of the Severity of Lower Abdominal Pain
Time frame: 14 days
Irritable Bowel Syndrome: Assessment of the Severity of Diarrhoea
Time frame: 14 days
Irritable Bowel Syndrome: Assessment of the Severity of Constipation
Time frame: 14 days
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Irritable Bowel Syndrome
Time frame: 14 days
Assessment of the Tolerability of Pantoprazole at Final Visit
Time frame: 14 days
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2012.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Gastroesophageal Reflux Disease
RecruitingObservational study
A Study to Evaluate the Efficacy and Safety of Long-term Administration of K-CAB Tab./K-CAB ODT(Tegoprazan) 25 mg as Maintenance Therapy Following the Treatment of GERD
Maintenance Therapy Following Treatment for Gastroesophageal Reflux Disease(GERD)
Active, not recruitingObservational study
RETHINK REFLUX Registry
Gastroesophageal Reflux
Recruiting
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
Mitral Regurgitation
Not yet recruitingPhase 4
Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With Obesity
Obese Adults
Recruiting
Mesh Vs Pledgets for Repair of Paraesophageal Hernia
Paraesophageal Hernia, GERD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Thomas D. Bethke, MD, MBA study director
Nycomed Deutschland GmbH, 78467 Konstanz, Germany
717 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Gastroesophageal Reflux Disease, run by Nycomed at 717 sites in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 May 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 717 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 24 Sep 2010). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Heartburn (time frame: 14 days). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2012.